This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Jan;20(1):1-14.

doi: 10.2165/00003088-199120010-00001.

Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies

P S Banerjee¹, J R Robinson

Affiliations

PMID: 2029799
DOI: 10.2165/00003088-199120010-00001

Review

Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies

P S Banerjee et al. Clin Pharmacokinet. 1991 Jan.

. 1991 Jan;20(1):1-14.

doi: 10.2165/00003088-199120010-00001.

Authors

P S Banerjee¹, J R Robinson

Affiliation

¹ School of Pharmacy, University of Wisconsin, Madison.

PMID: 2029799
DOI: 10.2165/00003088-199120010-00001

No abstract available

PubMed Disclaimer

Similar articles

Overview of drug product development.
Narayan P. Narayan P. Curr Protoc Pharmacol. 2011 Dec;Chapter 7:Unit 7.3.1-29. doi: 10.1002/0471141755.ph0703s55. Curr Protoc Pharmacol. 2011. PMID: 22147349 Review.
Pediatric drug development: formulation considerations.
Ali AA, Charoo NA, Abdallah DB. Ali AA, et al. Drug Dev Ind Pharm. 2014 Oct;40(10):1283-99. doi: 10.3109/03639045.2013.850713. Epub 2014 Jan 31. Drug Dev Ind Pharm. 2014. PMID: 24483293 Review.
Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs.
Löbenberg R, Kim JS, Amidon GL. Löbenberg R, et al. Eur J Pharm Biopharm. 2005 May;60(1):17-23. doi: 10.1016/j.ejpb.2004.11.010. Eur J Pharm Biopharm. 2005. PMID: 15848051
Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
Chen ML. Chen ML. Clin Pharmacol Ther. 2005 Oct;78(4):322-9. doi: 10.1016/j.clpt.2005.06.012. Clin Pharmacol Ther. 2005. PMID: 16198651 Review. No abstract available.
Drug delivery for optimised products: from product life-cycle management to first-generation product concepts.
Bhatt PP. Bhatt PP. Expert Opin Drug Deliv. 2005 Jan;2(1):1-2. doi: 10.1517/17425247.2.1.1. Expert Opin Drug Deliv. 2005. PMID: 16296731 No abstract available.

See all similar articles

Cited by

The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
Grundy JS, Foster RT. Grundy JS, et al. Clin Pharmacokinet. 1996 Jan;30(1):28-51. doi: 10.2165/00003088-199630010-00003. Clin Pharmacokinet. 1996. PMID: 8846626 Review.
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Ballester MR, Roig E, Gich I, Puntes M, Delgadillo J, Santos B, Antonijoan RM. Ballester MR, et al. Drug Des Devel Ther. 2015 Aug 5;9:4291-302. doi: 10.2147/DDDT.S86300. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26273191 Free PMC article. Clinical Trial.
An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.
Gendron A, Sirois G, Nair NP, Bloom D, Movin-Osswald G, Uppfeldt G. Gendron A, et al. J Psychiatry Neurosci. 1995 Jul;20(4):287-96. J Psychiatry Neurosci. 1995. PMID: 7647082 Free PMC article.
The influence of frusemide formulation on diuretic effect and efficiency.
Wakelkamp M, Blechert A, Eriksson M, Gjellan K, Graffner C. Wakelkamp M, et al. Br J Clin Pharmacol. 1999 Sep;48(3):361-6. doi: 10.1046/j.1365-2125.1999.00015.x. Br J Clin Pharmacol. 1999. PMID: 10510147 Free PMC article. Clinical Trial.
The influence of drug input rate on the development of tolerance to frusemide.
Wakelkamp M, Alván G, Scheinin H, Gabrielsson J. Wakelkamp M, et al. Br J Clin Pharmacol. 1998 Nov;46(5):479-87. doi: 10.1046/j.1365-2125.1998.00802.x. Br J Clin Pharmacol. 1998. PMID: 9833602 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. J Pharmacokinet Biopharm. 1983 Aug;11(4):401-24 - PubMed
1. Eur J Clin Pharmacol. 1986;31(4):423-6 - PubMed
1. J Clin Pharmacol. 1986 Jul-Aug;26(6):419-24 - PubMed
1. Br J Clin Pharmacol. 1982 Sep;14 (3):405-8 - PubMed
1. J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):716-22 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Other Literature Sources
- The Lens - Patent Citations Database